VERU INC. Embedded Derivative, Fair Value of Embedded Derivative Liability
VERU INC. (VERU) had Embedded Derivative, Fair Value of Embedded Derivative Liability of $0 as of 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability · last filed 2025-12-17
- 2025-09-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $0.00.
- 2025-06-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $0.00.
- 2025-03-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $0.00.
- 2024-12-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $0.00.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative Liability |
|---|---|
| 2025-09-30 | $0.00 10-K · filed 2025-12-17 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 |
| 2024-09-30 | $1.57M 10-K · filed 2025-12-17 |
| 2024-06-30 | $1.23M 10-Q · filed 2024-08-08 |
| 2023-09-30 | $1.33M 10-K · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |